Strategies that aim to enhance GJA1-20k expression or mimic its activity could potentially improve cardiac function, reduce the risk of arrhythmias, and protect the heart from ischemia/reperfusion injury. The gene discussed is GJA1; the disease is cardiac arrhythmia.